Latest News and Press Releases

TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced...

Acquisition adds TheraTears brand to Company’s leading eye care portfolioAcquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basisTransaction...

Company Exceeds Full Year 2021 Guidance for Revenue, Adjusted EPS and Free Cash FlowRevenue was $237.8 Million in Q4 and $943.4 in Full-Year Fiscal 2021Record Diluted EPS of $3.25 for Full-Year Fiscal...

TARRYTOWN, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 fourth quarter and year-end earnings release on...

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...

Revenue was $238.8 Million in Third Quarter Fiscal 2021Diluted EPS of $0.81 in Third Quarter Fiscal 2021Net Cash Provided by Operating Activities for First Nine Months of Fiscal 2021 Increased 10% to...

TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday,...

Revenue was $237.4 Million in Second Quarter Fiscal 2021, Approximately Flat to Prior YearDiluted EPS of $0.88 in Second Quarter Fiscal 2021; Non-GAAP Adjusted Diluted EPS of $0.78 up 15% from Prior...

TARRYTOWN, N.Y., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 second quarter earnings release on Thursday,...